SC 13D
SC 13D Filing
- Company
- CytoMed Therapeutics Ltd
- Filed
- May 19, 2023
- Accession Number
- 0001493152-23-018344
A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →